Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Can Amer Tower Amt Stock Beat The Market Price At 180.68 Up 0.42 20260410 Psec Stock Analysis Prospect Capital Corporation At 2.61 0.38 Dip Bdc Outlook 20260403 Is Algoma Steel Astl Stock Defensive In Downturns Price At 4.58 Up 3.85 20260408 Is Amicus Therapeutics Fold Stock Leading The Market Fold Q4 2025 Earnings Amicus Therapeutics Inc. Posts Wide Eps Miss No Revenue 20260406 1 Is Smurfit Sw Stock Overvalued Now Price At 41.77 Down 0.70 20260413 First FXNC Stock Technical Outlook Ticks Up 20260418 Opendoor OPENL Stock High Risk Trade Momentum Building 20260415 What Eureka EURK is doing that smart money tracks Calm 20260508 Crown Castle Inc CCI Completes Strategic Divestiture Positions Itself as US PurePlay Tower Leader KALA BIO KALA Stock Is It Testing Key Levels Q4 2025 EPS Tops Views How FormFactor FORM innovation pipeline shows in financials FormFactor Beats Estimates by 24 on Strong Demand Why Trevi Therapeutics TRVI could be the turning point youve been waiting for Momentum Building 20260511 AMWD Woodmark EPS crushes estimates by 60 yet stock slides 365 despite strong results TYG Tortoise management prioritizes North American energy infrastructure projects in latest quarterly earnings update ADT ADT Inc notches 102 percent Q1 2026 EPS beat shares climb five percent in todays trading session ET Energy shares gain 18 percent despite Q4 2025 EPS missing consensus analyst estimates Japer JSPRW Quarter Start iShares MSCI Germany ETF EWG Rides 2025 Global Equities Surge to Fresh Record Highs BGT BlackRock Floating Rate Income Trust releases quarterly report maintains focus on highyield debt markets Pensions Commission Urges Action to Close Gender Savings Gap in UK Retirement System BTS Shakira Madonna to Headline Inaugural World Cup Final Halftime Show A Win for FIFAs Commercial Playbook V2X Inc VVX Aerospace and Defense Sector Attracts ValueFocused Attention Whitehawk Therapeutics WHWK Declines 804 Amid Market Weakness 20260515 Woodside WDS Stock Analysis 284 Gain What to Watch 20260515 Feds Historic Overlap Powell and Warsh Prepare for First Joint FOMC Meeting in June TFS TFSL Flat at 1525 Consolidation Continues 20260518 Rand RAND Q1 2026 Earnings EPS 018 In Line with Estimates Texas Roadhouse TXRH Q1 2026 Earnings Surprise EPS 187 Up Significant Shoals SHLS Reports Strong Q1 2026 Revenue NA EPS Beats Apollo Global Management Acquires Majority Stake in Noble Environmental Strategic Expansion in Waste Management Nasdaq Leads Market Losses as Rising Oil Prices and Borrowing Costs Weigh on Sentiment JhunjhunwalaPartnered Fund Acquires Stake in Tourism Finance Corporation of India Management Discusses Outlook HRS Aluglaze Shares Surge After Strong FY26 Results Revenue Jumps 60 SP 500 Edges Higher as Healthcare and Tech Lead Communication Services Weighs WWE Saturday Nights Main Event 2026 Highlights Potential for TKO Groups Live Event Strategy VTAK Q1 2025 Earnings Significant EPS Miss Amidst Operational Challenges TDY Q1 2026 Earnings Earnings Beat Estimates Stock Rises STC Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Title Volume PHVS Q1 2026 Earnings NarrowerthanExpected Loss Despite No Revenue Stock Down MarineMax Inc HZO Q1 2026 Earnings EPS Falls Short of Expectations Amid Challenging Environment Liberty Latin America LILA Slides 3 as Macro Headwinds Weigh on Telecom Sector DuPont DD Surges 36 Analyzing the Breakout and Key Levels Digimarc DMRC Slides 59 as Selling Pressure Mounts Key Support in Focus GRND Q4 2025 Earnings EPS Miss Amid Flat Revenue Disclosure Stock Slips IBCP Q1 2026 Earnings Slight EPS Beat Amid Stable Operations Pluri Inc PLUR Q1 2026 Earnings WiderthanExpected Loss Sends Shares Lower Anthropic and Microsoft Negotiate AI Chip Partnership Following 5 Billion Investment SNOA Q1 2026 Earnings EPS Misses Expectations Stock Declines Jim Cramers Investing Club Morning Meeting Highlights Potential Upside and Market Calls BLTE Q4 2025 Earnings WiderthanExpected Loss as PreRevenue Biotech Remains Focused on Clinical Development